Search for: "Abbott Products Inc" Results 621 - 640 of 664
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
15 Mar 2008, 7:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
7 Mar 2008, 2:00 am
: (IP ThinkTank) Global - Copyright Copyright ‘evergreening’: (IP ThinkTank), The international copyright system: limitations, exceptions and public interest considerations for developing countries and the digital environment: (IP Justice), When copyright forces copying against your will: (Against Monopoly), (Techdirt), Encyclopedia of Life launches, publishes articles under CC licences: (creativecommons.org), Nine Inch Nails adopt successful experimental… [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
15 Jan 2008, 3:06 am
filed 03/22/07 1:07-cv-01721 Abbott Laboratories et al v. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v… [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
8 Dec 2007, 11:00 am
(more on the Wahaha v Danone dispute): (China Business Law Blog), What Global Players could learn from Wii v Vii [Nintendo's global new product launch mistakes]: (IPDragon), (China Law Blog), Junk Patents: (China Hearsay),Has your distributor (representative, manufacturer) in China registered your mark? [read post]
1 Dec 2007, 9:00 am
: (IAM),Latest WIPO SME newsletter: (WIPO),PharmaRoche extends patent fight (to include Abbott) over diabetes test strips: (IPLaw360),Drug innovation and marketing: (Tech Innovation and IP),WHO funded study reveals 3.1% of drugs sold in India are counterfeit suspects: (SpicyIP), Another piece on the impressive R&D programs of India's (generic?) [read post]
17 Oct 2007, 8:59 am
Donahue, Senior Vice President, General Counsel and Secretary of Rhodia Inc. [read post]